Table 3.
Medical Characteristics of Patients in the MetSO Trial.
| Variables | Intervention (%) | Control (%) | p |
|---|---|---|---|
| Hypertension | |||
| No | 7.7 | 7.1 | .835 |
| Yes | 92.3 | 92.9 | |
| Diabetes | .032 | ||
| No | 48.2 | 36.8 | |
| Yes | 51.7 | 63.2 | |
| Dyslipidemia | .849 | ||
| No | 31.1 | 30.2 | |
| Yes | 68.9 | 69.8 | |
| Heart problems | .654 | ||
| No | 70.4 | 72.6 | |
| Yes | 29.6 | 27.4 | |
| Arthritis | .828 | ||
| No | 50.9 | 49.7 | |
| Yes | 49.1 | 50.3 | |
| Respiratory problems | .738 | ||
| No | 76.9 | 78.4 | |
| Yes | 23.1 | 21.6 | |
| Cancer | .300 | ||
| No | 93.5 | 90.4 | |
| Yes | 6.5 | 9.6 |
MetSO, Metabolic Syndrome Outcome Cohort Study.
Values represent percentages for each measured baseline variable.